| Identification | Back Directory | [Name]
THYMOPOIETIN II (32-35) | [CAS]
85466-18-8 | [Synonyms]
TP-4
rgh0206
Thymocartin
TP II (32-35)
Thymocartinum
ARG-LYS-ASP-VAL
TP-4, ThyMocartin
H-ARG-LYS-ASP-VAL-OH
THYMOPOIETIN II (32-35)
Thymocartinum [INN-Latin]
L-Valine, L-arginyl-L-lysyl-L-α-aspartyl-
n-(n-(n(sup2)-l-arginyl-l-lysyl)-l-alpha-aspartyl)-l-valin
n-(n-(n(sup2)-l-arginyl-l-lysyl)-l-alpha-aspartyl)-l-valine
GLY-GLU-GLN-ARG-LYS-ASP-VAL-TYR-VAL-GLN-LEU-TYR-LEU: GENRKDVYVQLYL | [Molecular Formula]
C21H40N8O7 | [MDL Number]
MFCD00237285 | [MOL File]
85466-18-8.mol | [Molecular Weight]
516.59 |
| Hazard Information | Back Directory | [Uses]
Thymocartin (Thymopoietin II (32-35)) is the 32-35 fragment of the thymic factor (thymopoietin). Thymocartin has shown potential for immunodeficiency diseases research[1][2]. | [References]
[1] S Lang, et al. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol. 1996 Nov;48(11):1190-6. DOI:10.1111/j.2042-7158.1996.tb03919.x
[2] Ch B Felder, et al. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters. J Microencapsul. 2003 Sep-Oct;20(5):553-67. DOI:10.1080/0265204031000148059 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|